118th Congress Health
S. 2433: SUPPORT for Patients and Communities Reauthorization Act of 2023
Introduced
- Introduced (completed)
- Passed Senate (not reached)
- Passed House (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill reauthorizes through FY2028 programs and activities relating to mental health and substance use disorder services.
Reauthorized programs and activities include
- programs that enable access to drugs or devices that temporarily reverse opioid overdoses,
- activities to support the capacity of laboratories to detect synthetic opioids (e.g., fentanyl),
- residential treatment programs for pregnant and postpartum individuals, and
- training and workforce development for providers of mental health and substance use disorder services.
Read the full summary
The bill also modifies certain requirements relating to the regulation of controlled substances and the provision of mental health and substance use disorder services, including by requiring (1) the issuance of federal guidance to support at-home safe disposal systems for drugs, (2) studies to evaluate the efficacy of opioid treatment through buprenorphine and methadone, and (3) evaluations of the use of certain block grants by states to treat individuals with serious mental illnesses.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Who scored on this bill
No member has earned points from it yet.
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Bill Cassidy
History
- Introduced in the Senate by Bill Cassidy.
Show the full action history (2 actions)
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.